COViD-19 Tests
GENEDIA W COVID-19 Ag rapid test
The GENEDIA W COVID-19 Ag is a lateral flow immunochromatographic assay intended for qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 in nasopharyngeal swab specimens directly collected from individuals who are suspected of COVID-19 by a healthcare provider within the first seven days of symptom onset or for screening of individuals without symptoms.